Cas:693-23-2 Dodecanedioic acid manufacturer & supplier

We serve Chemical Name:Dodecanedioic acid CAS:693-23-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Dodecanedioic acid

Chemical Name:Dodecanedioic acid
CAS.NO:693-23-2
Synonyms:DDA;DDDA;MFCD00002735;n-Dodecanedioic acid;dodecane-1,12-dioic acid;Dodecanedioic acid;UNII-978YU42Q6I;EINECS 211-746-3;DODECANEDIOIC;n-Dodecanedioate;n-decane-1,10-dicarboxylic acid;decamethylenedicarboxylic acid;SL-AH;DODECANEDIOCACID;Corfree M 2;1,10-Decandicarboxylic Acid;1782580;1,12-Dodecanedioate;1,10-Decanedicarboxylic acid;n-Dodecane-α,ω-dioic acid;1,12-Dodecanedioic acid
Molecular Formula:C12H22O4
Molecular Weight:230.301
HS Code:2917190090

Physical and Chemical Properties:
Melting point:127-129 °C(lit.)
Boiling point:394.0±0.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.475
PSA:74.60000
Exact Mass:230.151810
LogP:2.92

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like DDA chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,12-Dodecanedioic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,n-Dodecane-α,ω-dioic acid Use and application,n-Dodecanedioate technical grade,usp/ep/jp grade.


Related News: The Darzalex-Rd regimen got its FDA go-ahead in transplant-ineligible patients in 2019 based on data from the same phase 3 MAIA trial showing it could pare down the risk of disease progression or death by 44% after a median follow-up of 28 months. Now, after 56.2 months of follow-up, over half of Darzalex patients were still alive without their disease worsening, a showing that’s again “unprecedented” for a front-line myeloma treatment, Tendler said. Dodecanedioic acid manufacturer Analogous to master cell lines used to manufacture biopharmaceutical drug products such as monoclonal antibodies, clonal master iPSC lines are a renewable source for manufacturing cell therapy products which are well-defined and uniform in composition, can be mass produced at significant scale in a cost-effective manner, and can be delivered off-the-shelf for patient treatment. Dodecanedioic acid supplier The mode of cooperation between domestic API companies and large international companies can lower the export threshold. Dodecanedioic acid vendor FT was defined as any difficulty paying medical bills, high financial distress, cost-related medication nonadherence, food insecurity, and/or foregone/delayed care due to cost. Dodecanedioic acid factory Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.